AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sarvagunaushdhi Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet

Diabetic patients using GlucoMet (Glimepiride/Metformin 0.5mg/500mg) tablets should be aware this medication, a dual-action anti-diabetic agent, manages type 2 diabetes by regulating blood glucose. Administered orally with meals, consistent daily dosing maximizes efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Discontinuing GlucoMet without medical supervision is risky, potentially leading to hyperglycemia and complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication is a cornerstone of comprehensive diabetes management, requiring adherence to a healthy diet, regular exercise, and weight management as directed by your doctor. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods, juice) is crucial. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. GlucoMet is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood cell and liver function tests, are recommended.

Primary Ingredients of StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the StayHappi Glimepiride+Metformin 0.5mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. StayHappi Glimepiride+Metformin 0.5mg/500mg tablets should be administered with meals.

How StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet works:

StayHappi Glimepiride/Metformin 0.5mg/500mg tablets combine glimepiride and metformin, two anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts threefold: it decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking StayHappi Glimepiride+Metformin 0.5mg/500mg tablets is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of StayHappi Glimepiride+Metformin 0.5mg/500mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against the risks before prescribing this medication. Seek medical advice before taking this medication if you are pregnant.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not use StayHappi Glimepiride+Metformin 0.5mg/500mg tablets due to the potential for infant harm. Evidence indicates the medication may be toxic to newborns.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should use StayHappi Glimepiride+Metformin 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is necessary. This medication is contraindicated in patients exhibiting severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use StayHappi Glimepiride+Metformin 0.5mg/500mg Tablets cautiously. Dosage modification may be necessary. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet :

Should you forget a StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on StayHappi Glimepiride+Metformin 0.5mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
StayHappi Glimepiride+Metformin 0.5mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). While rare, this risk is heightened in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
StayHappi Glimepiride/Metformin 0.5mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
StayHappi Glimepiride+Metformin 0.5mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of StayHappi Glimepiride+Metformin 0.5mg/500mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
StayHappi Glimepiride+Metformin 0.5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining StayHappi Glimepiride+Metformin 0.5mg/500mg tablets with alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
StayHappi Glimepiride+Met...
23
MRP 27
14% off